Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ADA | P00813 | 1/20 | 0.47 |
| ▸ | HINT1 | P49773 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1100799 | 1.00 | PNP (0.67) | PNPMEN1KMT2ACYP3A4MAPT | |
| SCHEMBL7057522 | 1.00 | PNP (0.67) | PNPMEN1KMT2ACYP3A4MAPT | |
| SCHEMBL17198373 | 0.91 | PNP (0.55) | PNPMEN1KMT2ACYP3A4MAPT | |
| SCHEMBL18519991 | 0.90 | PNP (0.54) | PNPMEN1KMT2ACYP3A4MAPT | |
| SCHEMBL462463 | 0.86 | PNP (0.52) | PNPMEN1KMT2ACYP3A4MAPT | |
| SCHEMBL28642522 | 0.86 | PNP (0.52) | PNPMEN1KMT2ACYP3A4MAPT | |
| SCHEMBL28603432 | 0.85 | PNP (0.52) | PNPMEN1KMT2ACYP3A4MAPT | |
| SCHEMBL6041233 | 0.84 | NT5E (0.57) | PNP | |
| SCHEMBL8630096 | 0.84 | NT5E (0.57) | PNP | |
| SCHEMBL8649743 | 0.82 | PNP (0.47) | PNPMEN1KMT2ACYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3642 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260049338-A1 | METHODS AND PRODUCTS FOR TRANSFECTING CELLS | FACTOR BIOSCIENCE INC (US) | 2026-02-19 | — | — | US | claimed |
| US-20250345406-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250325494-A1 | COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| US-12384740-B2 | Cationic lipids and transfection methods | FACTOR BIOSCIENCE INC. (US) | 2025-08-12 | — | — | US | claimed |
| WO-2025137275-A1 | NOVEL CAS NUCLEASES AND POLYNUCLEOTIDES ENCODING THE SAME | MODERNATX, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250188013-A1 | LIPID COMPOUND AND USE THEREOF | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-06-12 | — | — | US | claimed |
| WO-2025122721-A1 | CHIMERIC PROTEINS AND USES THEREOF | SHATTUCK LABS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| WO-2009143454-A2 | COMBINATION ANTITUMOR THERAPY | KEREOS, INC. (US) | 2009-11-26 | — | — | WO | claimed |
| US-20080120733-A1 | Rnai-Based Method for Selecting Transfected Eukaryotic Cells | GBF-GESELLSCHAFT FUR BIOTECHNOLOGISCHE FORSCHUNG (DE) | 2008-05-22 | — | — | US | claimed |
| EP-1759004-A1 | RNAI-BASED METHOD FOR SELECTING TRANSFECTED EUKARYOTIC CELLS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2007-03-07 | — | — | EP | claimed |
| WO-2005123925-A1 | RNAI-BASED METHOD FOR SELECTING TRANSFECTED EUKARYOTIC CELLS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2005-12-29 | — | — | WO | claimed |
| EP-1607482-A1 | RNAi-based methods for selection of transfected eucaryotic cells | GBF-GESELLSCHAFT FÜR BIOTECHNOLOGISCHE FORSCHUNG MBH (DE) | 2005-12-21 | — | — | EP | claimed |
| EP-1499187-A2 | IMMUNOSTIMULATORY G,U-CONTAINING OLIGORIBONUCLEOTIDES | Coley Pharmaceutical GmbH (DE) | 2005-01-26 | — | — | EP | claimed |
| US-20030232074-A1 | For stimulating immune activation; for screening immunostimulatory compounds | COLEY PHARMACEUTICAL GMBH (DE) | 2003-12-18 | — | — | US | claimed |
| WO-2003086280-A2 | IMMUNOSTIMULATORY G,U-CONTAINING OLIGORIBONUCLEOTIDES | COLEY PHARMACEUTICAL GMBH (DE) | 2003-10-23 | — | — | WO | claimed |
| EP-1194168-A2 | METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2002-04-10 | — | — | EP | claimed |
| WO-2000078941-A2 | METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2000-12-28 | — | — | WO | claimed |